Table_1_Effect of omalizumab on inflammatory markers in COVID-19: an exploratory analysis of the COVID-19 immunologic antiviral therapy with omalizumab (CIAO) trial.docx

Table_1_Effect of omalizumab on inflammatory markers in COVID-19: an exploratory analysis of the COVID-19 immunologic antiviral therapy with omalizumab (CIAO) trial.docx

Background<p>The CIAO trial recently demonstrated a probable clinical benefit of omalizumab in the treatment of severe COVID-19; however, the mechanism underlying this benefit remains unclear. Therefore, we sought to longitudinally assess the impact of omalizumab on serum cytokines in CIAO tri...

Full description

Saved in:
Bibliographic Details
Main Author: Connor Prosty (13014441) (author)
Other Authors: Michelle Le (3826864) (author), Yang Lu (59885) (author), Lauren Khoury (16900620) (author), Maxime Cormier (2697130) (author), Mathew P. Cheng (20286738) (author), Robert Fowler (662365) (author), Srinivas Murthy (188776) (author), Jennifer LY Tsang (2621734) (author), Duncan Lejtenyi (20286741) (author), Moshe Ben-Shoshan (4379185) (author), Elham Rahme (261544) (author), Shirin Golchi (13771192) (author), Nandini Dendukuri (118407) (author), Todd C. Lee (4030973) (author), Elena Netchiporouk (6599024) (author)
Published: 2024
Subjects:
Dermatology
Emergency Medicine
Gastroenterology and Hepatology
Geriatrics and Gerontology
Intensive Care
Medical Genetics (excl. Cancer Genetics)
Nephrology and Urology
Nuclear Medicine
Orthopaedics
Otorhinolaryngology
Pathology (excl. Oral Pathology)
Radiology and Organ Imaging
Foetal Development and Medicine
Obstetrics and Gynaecology
Family Care
Primary Health Care
Medical and Health Sciences not elsewhere classified
omalizumab
coronavirus
COVID-19
clinical trial
cytokine
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items